At a glance
- Originator Meiji Seika Kaisha
- Class
- Mechanism of Action Integrin alphaVbeta3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 10 Nov 2006 Discontinued - Preclinical for Ischaemic heart disorders in Japan (unspecified route)
- 03 Mar 2000 New profile
- 03 Mar 2000 Preclinical development for Ischaemic heart disorders in Japan (Unknown route)